Literature DB >> 28735507

Response to R-warfarin anticoagulant effect.

Ling Xue1, Nick Holford2, Li-Yan Miao1.   

Abstract

Entities:  

Keywords:  R-warfarin; anticoagulant effect

Mesh：

Substances：

Year:  2017        PMID： 28735507      PMCID： PMC5595937          DOI： 10.1111/bcp.13344

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  A Joint Model for Vitamin K-Dependent Clotting Factors and Anticoagulation Proteins.

Authors:  Qing Xi Ooi; Daniel F B Wright; R Campbell Tait; Geoffrey K Isbister; Stephen B Duffull
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447

2.  Response to R-warfarin anticoagulant effect.

Authors:  Ling Xue; Nick Holford; Li-Yan Miao
Journal:  Br J Clin Pharmacol       Date:  2017-07-23       Impact factor: 4.335

3.  R-warfarin anticoagulant effect.

Authors:  Roberto Padrini; Luigi Quintieri
Journal:  Br J Clin Pharmacol       Date:  2017-05-11       Impact factor: 4.335

4.  The Concise Guide to PHARMACOLOGY 2015/16: Enzymes.

Authors:  Stephen Ph Alexander; Doriano Fabbro; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2015-12       Impact factor: 8.739

5.  Investigation of the effects of herbal medicines on warfarin response in healthy subjects: a population pharmacokinetic-pharmacodynamic modeling approach.

Authors:  Xuemin Jiang; Elaine Y L Blair; Andrew J McLachlan
Journal:  J Clin Pharmacol       Date:  2006-11       Impact factor: 3.126

6.  Theory-based pharmacokinetics and pharmacodynamics of S- and R-warfarin and effects on international normalized ratio: influence of body size, composition and genotype in cardiac surgery patients.

Authors:  Ling Xue; Nick Holford; Xiao-Liang Ding; Zhen-Ya Shen; Chen-Rong Huang; Hua Zhang; Jing-Jing Zhang; Zhe-Ning Guo; Cheng Xie; Ling Zhou; Zhi-Yao Chen; Lin-Sheng Liu; Li-Yan Miao
Journal:  Br J Clin Pharmacol       Date:  2016-11-25       Impact factor: 4.335

7.  [Low Intensity Anticoagulation Therapy for Chinese Population with Heart Valve Replacement--3 000 Cases Follow-up].

Authors:  Jian-ping Xu; Ying-kang Shi; Li Dong; Yu Wei; Bo Fu; Ruo-fan Liu
Journal:  Sichuan Da Xue Xue Bao Yi Xue Ban       Date:  2016-01

8.  Human prothrombin metabolism in normal man and in hypocoagulable subjects.

Authors:  S S Shapiro; J Martinez
Journal:  J Clin Invest       Date:  1969-07       Impact factor: 14.808

9.  [The multicenter study on the registration and follow-up of low anticoagulation therapy for the heart valve operation in China].

Authors:  L Dong; Y K Shi; J P Xu; E Y Zhang; J C Liu; Y X Li; Y M Ni; Q Yang; T Han; B Fu; J Chen; L Ren; S L Wei; H Chen; K X Liu; F X Yu; J S Liu; M D Xiao; S M Wu; K L Zhang; H L Huang; S L Jiang; C H Qiao; C S Wang; Z Y Xu; X M Zhou; D J Wang; L X Ni; Y B Xiao; S L Jiang; G M Zhang; G Y Liang; S Y Yang; P Bo; Q J Zhong; J B Zhang; X Zhang; Y B Zhu; X Teng; P Zhu; F Huang; Y M Xiao; G Q Cao; H Tian; L M Xia; F L Lu; Y Q Liu; D X Liu; H Xu; Y Yuan; M Li; C Chang; X C Wu; Z Xu; P Guo; Y J Bai; W B Xue; X Y Jiang; Z H Na; Q Y Zeng; H Cai; Y L Wang; R Xiong; S Jin; X M Zheng; D Wu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2016-05-24

10.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
View more
  2 in total

1.  Response to R-warfarin anticoagulant effect.

Authors:  Ling Xue; Nick Holford; Li-Yan Miao
Journal:  Br J Clin Pharmacol       Date:  2017-07-23       Impact factor: 4.335

2.  Dicloxacillin induces CYP2C19, CYP2C9 and CYP3A4 in vivo and in vitro.

Authors:  Tore Bjerregaard Stage; Magnus Graff; Susan Wong; Louise Ladebo Rasmussen; Flemming Nielsen; Anton Pottegård; Kim Brøsen; Deanna L Kroetz; S Cyrus Khojasteh; Per Damkier
Journal:  Br J Clin Pharmacol       Date:  2018-01-10       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.